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One-sentence summary: Superresolution imaging of the pattern recognition receptor TLR4 reveals how 
different ligands control receptor dimerization. 
 
Editor’s summary: 
Resolving TLR4 signaling 
The pattern recognition receptor TLR4 recognizes lipopolysaccharide (LPS), a component of the 
cell wall of gram-negative bacteria. Ligand binding to TLR4 stimulates two distinct signaling 
pathways, and different LPS types and their derivatives can bias signaling through either pathway 
depending on their composition, which has implications for the use of TLR4 agonists as vaccine 
adjuvants. Krüger et al. used quantitative single-molecule localization microscopy to examine the 
effects of coreceptors and different LPS chemotypes on the oligomeric state of TLR4 in live cells. 
In the presence of coreceptors, TLR4 was evenly divided between monomeric and dimeric forms. 
Agonistic LPS shifted the balance towards dimeric TLR4, which activated an inflammatory 
signaling pathway, whereas an antagonistic LPS chemotype favored monomeric receptor. This 
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Abstract 
In humans, invading pathogens are recognized by Toll-like receptors (TLRs). Upon recognition of 
lipopolysaccharide (LPS) derived from the cell wall of gram-negative bacteria, TLR4 dimerizes 
and can stimulate two different signaling pathways, the proinflammatory, MyD88-dependent 
pathway and the antiviral, MyD88-independent pathway. The balance between these two pathways 
is ligand-dependent, and ligand composition determines whether the invading pathogen activates 
or evades the host immune response. We investigated the dimerization behavior of TLR4 in intact 
cells in response to different LPS chemotypes through quantitative single-molecule localization 
microscopy (SMLM). Quantitative super-resolved data showed that TLR4 was monomeric in the 
absence of its coreceptors MD2 and CD14 in transfected HEK 293 cells. When TLR4 was present 
together with MD2 and CD14, but in the absence of LPS, 52% of the receptors were monomeric 
and 48% were dimeric. LPS from Escherichia coli or Salmonella minnesota caused the formation 
of dimeric TLR4 complexes, whereas the antagonistic LPS chemotype from Rhodobacter 
sphaeroides maintained TLR4 in monomeric form at the cell surface. Furthermore, we showed 
that LPS-dependent dimerization was required for the activation of NF-κB signaling. Together, 
these data demonstrate ligand-dependent dimerization of TLR4 in the cellular environment, which 
could pave the way for a molecular understanding of biased signaling downstream of the receptor. 
 
Introduction 
Toll-like receptors (TLRs) are pattern recognition receptors, which play a pivotal role in the innate 
immune response and recognize danger- (or damage-) associated molecular patterns (DAMPs), 
and pathogen-associated molecular patterns (PAMPs) (1). The most studied receptor among the 
TLR family is TLR4, which has as its canonical ligand lipopolysaccharide (LPS), a major 
component of the cell wall of gram-negative bacteria (2, 3). TLR4 is a transmembrane receptor, 
comprising an extracellular domain that is connected to the intracellular domain by a leucine-rich 
repeat motif. LPS is first recognized by the LPS-binding protein (LBP) (4, 5). Subsequently, the 
TLR4 coreceptor CD14 (cluster of differentiation 14) transfers LPS to the extracellular myeloid 
differentiation protein-2 (MD2)-TLR4 heterodimer. This TLR4-MD2 heterodimer then dimerizes 
with another TLR4-MD2 complex and recruits specific intracellular adaptor molecules to promote 
the activation of downstream signaling pathways. A unique feature of TLR4, compared to other 
TLRs, is its ability to activate two distinct signaling pathways: the Myeloid differentiation primary 
response gene 88 (MyD88)-dependent pathway and the MyD88-independent pathway (6, 7). Both 
pathways result in the activation of nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) signaling, but only the MyD88-independent pathway stimulates signaling by interferon 
regulatory factor 3 (IRF3) (8–11). It is well understood that MD2 is necessary for TLR4 signaling 
and especially for the dimerization of TLR4 in the receptor complex, whereas the role of CD14 in 
the dimerization process is less well-defined (12–14). 
 
LPS is composed of three major components: an O side chain, a core oligosaccharide, and lipid A 
(15, 16). The lipid A moiety is a very diverse molecule and differs structurally depending on the 
bacterial strain from which the LPS is derived. Lipid A from Escherichia coli LPS (LPSEC) is 
hexa-acylated, whereas lipid A from Salmonella minnesota LPS (LPSSM) is hepta-acylated (16, 
17). In contrast, the lipid A moiety from Rhodobacter sphaeroides LPS (LPSRS) is penta-acylated 
and antagonizes the receptor (18, 19). These acylation patterns in different LPS chemotypes not 
only affect the agonistic properties of LPS, but also result in biased signaling in the glioma cell 
line U251. In these cells, LPSEC induces a substantial inflammatory response through NF-κB, 
whereas LPSSM is less pro-inflammatory and has a greater stimulatory effect on IRF3 signaling 
(20). Additionally, differences in downstream signaling do not depend on the formation of larger 
clusters of TLR4 (20). How LPSRS binds to LBP, CD14, and MD2, is less well-understood; 
however, the dimerization of two TLR4-MD2 complexes is inhibited and signaling is abrogated 
(21, 22). Here, we investigated the ligand-induced dimerization of TLR4 in intact cells using 
quantitative, single-molecule localization microscopy (SMLM). 
 
SMLM is a powerful tool that is sued to investigate cellular structures in situ that have a spatial 
resolution well below the diffraction limit of light microscopy (23). Single fluorescent emitters are 
separated over time and their localizations are determined with high precision. The reconstruction 
of the molecular coordinates results in a super-resolved image, giving insights into the nanoscale 
organization of the target cellular structure. SMLM requires photoactivatable or photoswitchable 
fluorophores, which can either be fluorescent proteins (FPs), such as those used in photo-activated 
localization microscopy (PALM), or organic fluorophores, such as those used in (direct) stochastic 
optical reconstruction microscopy (STORM or dSTORM) (24–26). SMLM is particularly suited 
to the study of membrane proteins and it provides information on nano-scale cluster size, 
distribution, and molecular numbers (27–29). 
 
Robust quantitative information can be obtained from SMLM data if proteins are labeled 
stoichiometrically, which can be achieved through the conjugation of a photoactivatable FP (paFP) 
to the protein of interest (30). A common paFP for this purpose is mEos2, which is 
photoconvertible from a green to an orange form after irradiation with ultraviolet (UV) light (31). 
Advanced SMLM concepts, which in addition to localizing single fluorophores make use of the 
intrinsic “blinking” of paFPs, even enable the prediction of copy numbers from protein clusters 
that cannot be resolved with super-resolution SMLM, and thus can provide insight into the 
oligomeric state of a membrane protein (32–34). Because oligomerization often is the starting 
point that initiates signaling pathways mediated by receptors, the quantitative information obtained 
in situ is highly relevant (35–37). 
 
Here, we applied quantitative SMLM imaging to determine the oligomeric state of TLR4 in situ. 
We focused on the resting receptor and the roles of the coreceptors MD2 and CD14, and we 
explored how LPS from different bacterial species influenced the ratio between the monomeric 
and dimeric forms of the receptor. Clustering of TLR4 on the plasma membrane in response to 
LPS is controversially discussed (20, 38). However, investigations on higher-order clustering of 
TLR4 with the help of conventional SMLM techniques are not sensitive enough to decipher 
monomeric TLR4 from dimeric TLR4. 
 
Using SMLM, we distinguish between monomeric TLR4 in the absence of CD14 and MD2, and 
a mixed population of monomeric and dimeric TLR4 in their presence. We found a correlation 
between dimerization of TLR4 and agonistic LPS, whereas the penta-acylated, antagonistic LPSRS 
favored monomeric TLR4. To demonstrate the functionality of the TLR4_mEos2 construct in 
human embryonic kidney (HEK) 293 cells, we performed NF-κB gene reporter assays and 
observed increased NF-κB activity in response to agonistic LPS forms, but no increase in NF-κB 
signaling in response to LPSRS. In addition, we did not detect differential activation patterns of 
NF-κB and IRF3 in HEK 293 cells expressing TLR4_mEos2 after exposure to different agonistic 
LPSs. Finally, higher-order oligomerization of TLR4 was not observed after treatment with LPS. 
 
Results 
Quantitative SMLM of calibration proteins 
We used SMLM and quantitative analysis to determine the oligomeric state of TLR4 in clusters 
consisting of the TLR4-MD2 complex in cells. For this experimental approach, an SMLM image 
stack of a cellular target protein labeled with a paFP was recorded, from which a super-resolved 
image was generated (Fig. 1A). Typically, a single paFP emits multiple times during an imaging 
experiment (and before it undergoes photodestruction), which appears as so-called “blinking” or 
re-occurrence of fluorescence events (Fig. 1A). This blinking behavior is described by simple 
kinetic equations; a simple yet robust analysis approximates the histogram of the blinking events 
with an appropriate model function (Fig. 1A) (see Materials and Methods) (34, 39). The strength 
of this quantitative approach is that information about the stoichiometry of proteins within single-
protein clusters can also be obtained: although the individual proteins within a protein cluster 
cannot be resolved optically even with super-resolution microscopy, the blinking pattern of the 
paFPs conjugated to these proteins changes with respect to the number of protein units. An accurate 
analysis requires that a target protein is labeled stoichiometrically, for example with a paFP. The 
analysis of blinking cycles also accounts for fluorescent proteins that are not detected, for instance 
through misfolding, premature bleaching, etc. (for a detailed description of the experimental 
approach, see Materials and Methods and Fig. 1) (31, 40–42). Analyzing the blinking pattern from 
about 100 clusters is statistically sufficient to determine the oligomerization state of mEos2-tagged 
membrane proteins (39). 
 
Here, we used quantitative SMLM to determine the oligomeric state of TLR4 under different 
cellular conditions. More specifically, we analyzed the fraction of monomeric and dimeric TLR4 
on the plasma membrane of HEK 293 cells. We first performed calibration experiments in HEK 
293 cells by expressing two proteins of known stoichiometry, namely cluster of differentiation 86 
(CD86) and cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4), which are known to be 
monomeric and dimeric proteins, respectively (34, 43–46). Both proteins were expressed in HEK 
293 and PALM images were acquired. CD86_mEos2 showed individual clusters, which were 
uniformly distributed on the cell surface (Fig. 1B). To determine the oligomeric state of 
CD86_mEos2, we performed a blinking distribution analysis and generated a histogram of the 
relative frequency distribution of blinking events (herein referred to as blinking number 
distribution) (Fig. 1C). As expected CD86_mEos2 showed a clear monomeric distribution, which 
was very well approximated by the corresponding fit function (Fig. 1C) (34). This fit function 
returned the value p= 0.32 (which reports on the fraction of mEos2 molecules that did not blink), 
which is in good accordance with published values for CD86_mEos2 in other cell lines (34). The 
same procedure was performed for CTLA-4_mEos2. Super-resolved images showed a uniform 
distribution of clusters at the cell-surface (Fig. 1D) and a distribution of blinking events (Fig. 1E) 
that was very well approximated by a dimeric model. In addition to the p value, this model reports 
on the fraction of molecules that were not detected (for example, because of photo-damage or 
misfolding), which we termed q and had the value q = 0.29 (Table 1). This value reflects a detection 
efficiency of mEos2 of 71%, which is in good agreement with the detection efficiencies of mEos2 
in similar experiments (41, 47). We determined the experimental localization precision of our 
SMLM experiments to be 15.1 ± 0.4 nm for CD86_mEos2 and 16.1 ± 1.0 nm for CTLA-4_mEos2 
using a nearest-neighbor analysis (Table 1) (48). This translates into a spatial resolution of 
approximately 50 nm (assuming two point objects), which is not sufficient to resolve individual 
proteins within a protein cluster (49). 
 
Dimerization of TLR4 in HEK 293 cells 
Next, we investigated the proportion of monomers and dimers of TLR4 in resting HEK 293 cells. 
These cells represent an excellent model system in which to study TLR4 signaling because they 
lack endogenous TLR4, CD14, and MD2, however they have the necessary intracellular signaling 
components required for the MyD88-dependent, but not MyD88-independent, pathway (50). We 
recorded super-resolved images of HEK 293 transfected with plasmid encoding TLR4_mEos2, 
and selected for analysis only those cells that exhibited fewer than four protein clusters per µm² of 
plasma membrane, which is in the same range as the copy numbers of endogenous TLR4 in U251 
cells (20). This selection criterion likely ensured that dimerization as a result of protein 
overexpression was largely excluded from the analysis. At the same time, errors in the analysis 
because of an increasing number of overlapping protein clusters in the microscopy images were 
minimized. We analyzed the blinking number distributions of TLR4_mEos2 generated under 
different experimental conditions, which we approximated with suitable model functions that 
reported on the proportions of monomeric and dimeric TLR4 (Fig. 2A). 
 
First, we investigated the stoichiometry of TLR4_mEos2 clusters in the absence of CD14 and 
MD2. HEK 293 cells were transiently transfected with plasmid encoding TLR4_mEos2, super-
resolved images were acquired, and the blinking distribution was generated. In the absence of 
CD14 and MD2, we found that TLR4 exclusively formed monomers (Fig. 2B). We determined a 
p value of 0.31, which is very similar to the p value that we observed in the calibration experiment 
with CD86 (Fig. 1C). In HEK 293 cells that stably expressed TLR4_mEos2 with CD14 and MD2, 
the blinking distribution of TLR4_mEos2 was consistent with the presence of both monomeric 
(52%) and dimeric (48%) TLR4 (Fig. 2C). These results support the importance of the coreceptors 
CD14 and MD2 in enabling TLR4 dimerization (13, 51). However, it cannot be excluded that this 
dimerization was the result of the activation of TLR4 signaling by endogenous ligands. 
 
We next investigated how different LPS chemotypes influenced the dimerization behavior of 
TLR4. We used a cell line stably expressing CD14 and MD2 (HEK293_CD14MD2 cells) and 
performed transient transfection of these cells with plasmid encoding TLR4_mEos2. These 
HEK293_CD14MD2_TLR4mEos2 cells were treated with LPS derived from E. coli, S. minnesota, 
or R. sphaeroides, super-resolved SMLM images were acquired, and the blinking distributions 
were analyzed (Fig. 2, D to F). Each of the various chemotypes of LPS resulted in a uniform 
distribution of TLR4 on the cell surface and no formation of larger clusters was observed, which 
is consistent with a previous study (20). The blinking distributions generated in response to LPSEC 
and LPSSM were consistent with mixed populations of monomeric and dimeric TLR4 (Fig. 2, D 
and E).In comparison to untreated cells (Fig. 2C), both LPSEC and LPSSM induced the formation 
of dimeric TLR4 (Fig. 2, D and E). LPS from R. sphaeroides is a well-known antagonist of TLR4 
signaling; therefore, we used it to investigate the oligomerization behavior of TLR4 under 
antagonistic influence (19). The blinking distribution showed exclusively monomers of TLR4 (Fig. 
2F) and was distinct from the distributions caused by LPSSM or LPSEC (Fig. 2, D and E).  
 
We next performed gene reporter assays to assess the functionality of the fluorescently tagged 
TLR4 constructs (Fig. 3A). Here, we cotransfected HEK293_CD14MD2 cells with an NF-κB–
dependent luciferase reporter gene and plasmids encoding TLR4_GFP, TLR4_mEos2, or EGFP. 
In the absence of LPS, we observed an increase in NF-κB activity in cells expressing TLR4_GFP 
or TLR4_mEos2 compared to that in cells expressing EGFP alone. The functionality of the 
exogenous receptor was confirmed in experiments in which LPSEC caused a substantial increase 
in NF-κB activity in cells expressing TLR4_GFP or TLR4_mEos2, but not in cells expressing 
EGFP alone. 
 We then investigated intracellular signaling activation in experiments in which 
HEK293_CD14MD2 cells were cotransfected with plasmids encoding TLR4_mEos2 and a NF-
κB-dependent luciferase reporter. Treatment of these cells with LPSEC or LPSSM resulted in a 
substantial increase in NF-κB-dependent luciferase activity compared to that in untreated cells 
(Fig. 3B). Together with the data obtained from quantitative SMLM, these findings show a 
correlation between dimerization and signaling through TLR4. This finding is also consistent with 
the NF-κB activity measured in response to LPSRS, where no statistically significant difference 
compared to that in control cells was observed (Fig. 3B). Furthermore, LPSRS prevented NF-κB 
activity in cells treated simultaneously with either LPSEC or LPSSM (Fig. 3B). The concentrations 
of LPSRS used in this study were chosen to completely inhibit TLR4 dimerization and signaling 
(22). A study showed that LPSEC and LPSSM exhibit functional selectivity in U251 glioma cells, 
promoting differential activation of NF-κB and IRF3 (20). In these U251 cells, LPSEC had a more 
substantial effect on NF-κB signaling than on IRF3 signaling, whereas the reverse was true for 
LPSSM. Therefore, we investigated whether LPSEC and LPSSM were similarly capable of biased 
signaling in HEK293_CD14MD2 cells cotransfected with plasmids encoding TLR4_mEos2 and 
an IRF3 reporter. However, we were unable to detect any substantial changes in IRF3 activity in 
response to either LPSEC or LPSSM, similar to control cells (Fig. 3C). 
 
Discussion 
We used quantitative SMLM to determine the different oligomerization states of TLR4_mEos2 in 
HEK 293 cells in situ. We specifically investigated how TLR4 oligomerizes in the presence and 
absence of the coreceptors MD2 and CD14 and in response to different LPS chemotypes. 
Quantitative SMLM makes use of the observation that single fluorophores show blinking, namely 
re-occurrence of a fluorescence signal over time. This blinking follows kinetic equations, and as 
such the analysis of blinking distributions enables information about the number of fluorophores 
within a spot to be extracted. This analysis also accounts for the incomplete photodetection of 
fluorophores (q value, see Materials and Methods). Here, we used the photoactivatable fluorescent 
protein mEos2 for quantitative SMLM of TLR4 in HEK 293 cells and analyzed the oligomeric 
states of TLR4_mEos2 protein clusters in the plasma membrane. 
 
An important validation of quantitative SMLM is to analyze the blinking distribution of calibration 
proteins that are exclusively monomeric or dimeric. We used monomeric CD86 and dimeric 
CTLA-4 and validated their oligomeric state in HEK293 cells. The  fit produced results (blinking 
probability p=0.31, fraction of undetected molecules q=0.29) that were consistent with values 
determined for these two proteins in other cell lines (34). Note that quantitative SMLM requires 
criteria for the selection of protein clusters that are analyzed (see Materials and Methods and Fig. 
1A). Super-resolved protein clusters that, for example, are either too close to a second protein 
cluster or exhibit an irregular shape must be excluded, and the cellular background signal and 
membrane curvature generate challenges for this kind of super-resolution microscopy (52, 53). 
This could be addressed in the future by the development of more sophisticated image analysis 
tools that are able to resolve overlapping protein clusters and that can perform in the presence of a 
high background signal. 
 
The cluster selection procedure that we used for this study excluded large clusters from our 
analysis. We focused on the distribution of TLR4 monomers and dimers and how this distribution 
was affected by LPS. It should be noted that in our current study we did not observe clusters of 
TLR4 in the PALM images that would indicate a higher order clustering of the receptor or clusters 
larger than 80 nm in radius. Another concern is the use of a sufficient number of clusters needed 
to generate a statistically meaningful blinking number distribution. In this study, we selected at 
least 500 protein clusters for analysis from at least 9 individual cells (for each condition), which 
largely exceeds the theoretical prediction of at least 100 protein clusters needed for a robust 
determination of the oligomeric state (39). 
 
We next investigated the dimerization behavior of TLR4 in response to different LPS chemotypes. 
All super-resolved images of TLR4_mEos2 displayed no visible differences in the cluster sizes on 
intact cells, and no formation of clusters larger than 80 nm in radius was observed. This finding is 
consistent with a study that investigated the clustering of TLR4 on glioma cells using 
immunostaining and dSTORM imaging and reported a cluster size of approximately 60 nm for 
TLR4 in response to either LPSEC or LPSSM (20). In contrast to these findings, another study 
reported large-scale clustering of TLR4 in response to LPSEC (38). The discrepancies between the 
studies performed by Aaron et al. and Zeuner et al. may be explained by the use of different cell 
lines and different experimental procedures. First, Aaron et al. investigated TLR4 in mouse 
macrophage-like cells with immunofluorescence labeling (38), and discrepancies in the cluster 
sizes of TLR4 could be the result of different behaviors of mouse and human TLR4 (54). Second,  
SMLM imaging  with organic fluorophores requires high laser intensities to ensure efficient 
photoswitching, and thus optimal imaging conditions, and it requires careful adjustment of the 
imaging conditions (55). Finally, it is also possible that HEK 293 cells do not support the formation 
of large TLR4 clusters; however, large receptor clusters were reported for the epidermal growth 
factor receptor (EGFR) and the β2-adrenergic receptor (56, 57). Nevertheless, both studies were 
not sensitive enough to decipher the dimerization behavior of TLR4 (20, 38). 
 
Here, we analyzed TLR4 oligomerization in situ and performed quantitative SMLM imaging of 
TLR4 before and after treatment with different LPS chemotypes, as well as with and without MD2 
and CD14 in HEK 293 cells. These cells represent an excellent model in which to study TLR4 
signaling because they lack endogenous TLR4 and TLR2, which activate MyD88-dependent 
signaling through other pathogen-derived molecules (that are often present in low-purity LPS 
preparations) (58). Investigations of the oligomerization behavior of TLR4 under different 
experimental settings enabled us to propose a model for the activation and dimerization of TLR4. 
Consistent with previous data, we observed that in the absence of MD2 and CD14, TLR4 was 
found exclusively as a monomer at the cell surface in HEK 293 cells (13, 51). When TLR4 was 
expressed together with MD2 and CD14, we detected a substantial switch with the appearance of 
TLR4 dimers. The existence of dimers in the absence of LPS might be explained by the activation 
of the receptor with as-yet undefined endogenous ligands or DAMP-like proteins (18). Our 
luciferase activity assays inferred that these dimers were active because the presence of CD14 and 
MD2 (rather than EGFP) in HEK cells expressing TLR4 was sufficient to promote NF-κB 
activation (Fig. 3). We hypothesize that this could be due to potential DAMP-like proteins, such 
as heat shock proteins, β-defensin, or high mobility group box one (HMGB1), which may have 
been present in the culture medium or signaled through the activation of intracellular TLR4 (18). 
The binding of endogenous ligands to TLR4 is a matter of an ongoing scientific debate and thus 
cannot be excluded as a factor responsible for the dimeric fraction of TLR4 (59, 60). Functional 
selectivity of LPSEC and LPSSM was tested in HEK293_CD14MD2 cells transfected with plasmid 
encoding TLR4_mEos2 using an IRF3-biased signaling assay. However, none of the different LPS 
chemotypes stimulated any substantial increased in IRF3 activity. HEK 293 cells have low 
amounts of TIR-domain-containing adaptor-inducing interferon (TRIF), which is an essential 
intracellular adaptor protein that promotes the TLR4-stimulated, MyD88-independent activation 
of IRF3 (61). A study examining IRF3 activation in HEK 293 cells used cells transfected with 
plasmid encoding TRIF to circumvent this problem (50). Although the downstream signaling 
events were not the primary aim of our study here, it would be interesting to investigate which 
intracellular signaling proteins are required to induce biased signaling at TLR4. 
 
After applying different LPS chemotypes to TLR4, the ratios of monomeric and dimeric 
complexes changed. LPSSM and LPSEC resulted in mainly dimeric TLR4 (73 and 74%, 
respectively). Nevertheless, monomeric TLR4 was also present on the plasma membrane, which 
might be explained by the recycling of TLR4 back to the plasma membrane or the incomplete 
occupancy of TLR4 complexes by LPS. In contrast, LPSRS resulted in only monomeric TLR4 and 
an NF-κB activity similar to that in unstimulated cells. Note that there was no direct relationship 
between the dimerization of TLR4 and NF-κB activity, especially in the case of treatment with 
LPSRS. In untreated cells, we readily detected dimeric TLR4 at the cell surface; however, the extent 
of NF-κB activation was similar to that observed in cells in which no dimers were detectable in 
response to LPSRS (Fig. 3B). Because we know of no evidence of the activity of TLR4 dimers that 
exist under basal conditions, we hypothesize that the basal activity in each case is due solely to 
intracellular TLR4 activity, with no stimulation of NF-κB activity by cell surface receptors. In 
support of this hypothesis, TLR4 is found in the cytoplasm of dendritic cells and can be activated 
by intracellular Neisseria meningitides in these cells (62). Moreover, in macrophages, intracellular 
TLR4 signaling leads to an increase in the abundance of MCP-1 mRNA, an NF-κB target gene, 
which suggests that intracellular TLR4 is functional (63). We suggest that intracellular TLR4 
activation in transfected HEK 293 cells could be stimulated by endogenous intracellular ligands 
(for example, heat shock proteins). It is unlikely that this intracellular signaling would be affected 
by LPSRS and this could explain why LPSRS, although it led to the maintenance of TLR4 monomers 
at the cell-surface, did not affect the basal NF-κB activity observed in untreated cells. Overall, our 
results are in agreement with data describing the prevention of dimerization and signaling behavior 
of TLR4 upon treatment with antagonistic ligands (21). 
 
A photobleaching study of the dimerization of TLR4 reported similar results to ours (64). Briefly, 
Yang et al. showed that 87.5% of TLR4 was monomeric, whereas 12.5% of TLR4 was dimeric in 
cells in the absence of LPS (64). After treatment with LPSEC, the distribution changed to 48.3% 
monomeric and 51.7% dimeric. However, photobleaching is a diffraction-limited method that is 
often hampered by the fact, that only sparse samples can be investigated (less than 2 particles per 
µm²) (65). This fact might explain the different distributions of monomeric and dimeric receptors 
described here and in previously published studies. We performed super-resolution imaging below 
the diffraction limit of light which enabled the investigation of receptors on the plasma membrane 
of intact cells at an abundance similar to that of endogenous TLR4 (20). However, that TLR4 
exhibited an increased tendency to exist as dimers in response to agonistic LPS is evident in both 
studies. Overall, our data provide information on the dimerization of TLR4 in intact cells, which 
we elucidated with SMLM. Future research on TLR4 and receptors that undergo oligomerization 
can use SMLM to obtain information on the oligomerization state and organization of the receptor. 
These findings will help to understand the pivotal start of signaling responses, which is often 
dependent on the change of oligomeric state of the receptor. 
 
Materials and Methods 
Cell culture 
HEK 293 cells (a kind gift from Hartmut Niemann, University of Bielefeld, Germany) and 
HEK293_CD14MD2 cells (InvivoGen) were cultured at 37°C and 5% CO2 in Dulbecco’s 
Modified Eagle Medium (DMEM, Life Technologies) supplemented with 1% GlutaMAX (Gibco) 
and 10% fetal bovine serum (FBS, Capricon). For luciferase assays, DMEM, GlutaMAX, and FBS 
were sourced from Sigma-Aldrich (FBS lot: 126K3398). 
 
Cleaning and coating of microscopy slides 
Glass slides (PLANO GmbH,) were used for the imaging of transfected cells. Slides were 
incubated in isopropyl alcohol (Sigma Aldrich) for 30 min, rinsed with endotoxin-free water, dried, 
and plasma-cleaned with N2 (Diener Electronic) for 15 min. Slides were then coated for 1 hour 
with polyethylene glycol (PEG, Rapp Polymere) covalently coupled at either end to poly-L-lysine 
(PLL, Sigma) and a peptide containing the RGD-binding motif (PLL-PEG-RGD (66), 0.8 mg/ml), 
washed extensively with endotoxin-free water, and dried with N2. 
 
Plasmids 
A plasmid encoding human TLR4 (hTLR4) with the cDNA encoding mEos2 fused to the C 
terminus was generated by standard cloning techniques. Three inserts were generated as follows. 
First, part of the CMV promoter and the 5’ end of hTLR4 was excised at the Nde I and Hpa II sites 
from pRP-CMV-hTLR4-mEos3.2 (generated by Cyagen Biosciences). Second, the stop codon of 
hTLR4 was removed by PCR using the following primers: Forward: 5’-
GGAATGAGCTAGTAAAGAATTTAGA-3’; Reverse: 5’-
TGGCAGGAAGCAACATCTATCCTCGAGTATATA-3’. The product was then digested with 
Hpa II and Xho I. Third, the sequence encoding mEos2 was removed from pRSETa-mEos2 (gift 
from Loren Looger, Addgene plasmid #20341) at the Xho I and Not I sites. The plasmid 
pcDNA3.1(+) was digested with Nde I and Not I and the three inserts were ligated to generate 
pcDNA3.1-hTLR4-mEos2. The plasmids encoding the monomeric CD86_mEos2 protein and the 
dimeric CTLA-4_mEos2 protein were described previously (34). 
 
Cell transfections 
For transfections, cells were seeded in 6-well plates and cultured until ~90% confluent. 
Lipofectamine 3000 (Thermo Scientific) was used according to the manufacturer’s guidelines to 
transfect the cell lines with plasmids encoding TLR4_mEos2, CD86_mEos2, or CTLA-4_mEos2, 
as appropriate (2.5 µg of endotoxin-free plasmid was used per transfection). Cells were then kept 
in phenol-red-free medium, replated on cleaned and coated glass slides, and cultured overnight in 
the incubator to adhere before they were starved in FBS-free medium for at least 4 hours. For the 
luciferase measurements, HEK293_CD14MD2 cells were transfected 4 hours before serum-
starvation with endotoxin-free TK (NF-κB6) LUC (for NF-κB reporter gene assay) or with IRF-3-
Gal4 (pEFGal4-IRF-3) and UAS-LUC (p55UASGLuc), both kindly provided by K. Fitzgerald, 
University of Massachusetts Medical School, Worcester, USA, (for the IRF3 reporter gene assay), 
pcDNA3.1-hTLR4-mEos2, and pRL-CMV (Promega Corporation) (at a ratio of 1:1:2) with 
Turbofect Transfection Reagent (Thermo Fisher Scientific) according to the manufacturer’s 
guidelines. To test TLR4 functionality, the cells were transfected with plasmids encoding EGFP, 
TLR4_GFP (InvivoGen) (67), or TLR4_mEOS2. 
 
LPS treatment 
After the cells were subjected to serum starvation, LPSEC (Ultrapure Escherichia coli K12, 
InvivoGen) or LPSSM (Ultrapure S. minnesota R595, InvivoGen) were applied to the cells in FBS-
containing medium for 30 min (each at a final concentration of 1 µg/ml). For experiments with 
LPSRS (Ultrapure R. sphaeroides, InvivoGen), LPS (10 µg/ml) was added to the serum-free 
medium and the cells were treated for 8 hours. The concentration of LPSRS was chosen to ensure 
complete antagonism of TLR4 (22). All LPS chemotypes were ultrapure, dissolved in endotoxin-
free water, and sonicated for at least 5 min before being used. As a control, cells were not treated 
with any LPS chemotype. After LPS treatment, the cells were washed with pre-warmed 400 mM 
sucrose in phosphate-buffered saline (PBS) and afterwards incubated for 15 min with fixation 
buffer [4% formaldehyde (methanol-free) Thermo scientific], 0.2% glutaraldehyde (Sigma 
Aldrich), and 400 mM sucrose in PBS. Samples were then washed extensively in PBS. Fixation 
of HEK 293 cells expressing CD86_mEos2 or CTLA-4_mEos2 was performed as described earlier 
with no prior stimulation with LPS. For the luciferase measurements, cells were serum-starved for 
4 hours with or without LPSRS (10 µg/ml). The cells were then left untreated or were treated with 
LPSRS (10 µg/ml) for 48 hours in normal culture medium containing ultrapure LPS derived from 




NF-κB reporter activation and IRF3 reporter activation (firefly luciferase activity) versus Renilla 
luciferase activity were examined with a Dual-Luciferase Reporter Assay System (Promega 
Corporation) according to the manufacturer’s guidelines. All luciferase measurements were 
performed with a Lucy 1 microplate reader (Anthos Labtec). 
 
Single-molecule localization microscopy 
For SMLM measurements of TLR4_mEos2 in HEK 293 cells or HEK293_CD14MD2 cells and 
measurements of the calibration proteins (CD86_mEos2 and CTLA-4_mEos2) in HEK 293 cells, 
a custom-built setup was used as previously described (34). Briefly, a 568-nm laser (Sapphire 568 
LP, Coherent) and a UV laser (405 nm, Cube 405-50C, Coherent) were focused on the back focal 
plane of an Olympus IX-71 inverted microscope equipped with a 100× oil immersion objective 
(PLAPO 100× TIRFM, NA ≥ 1.45, Olympus) and dichroic mirrors (AHF). To minimize drift, a 
“nose piece” (Olympus) was mounted onto the objective, which maintained the distance between 
the sample and the objective. Fluorescence was detected with an EMDDC camera (iXon3 and 
iXon Ultra, Andor) after filtering with a bandpass (BrightLine HC 590/20, AHF). Samples were 
imaged in PBS. Recording was started before the cells were illuminated with the 568 nm and UV 
lasers. Imaging was performed in total internal reflection (TIRF) mode with a frame rate of 10 Hz 
and under continuous 568-nm laser illumination (0.5 kW/cm²) and increasing UV illumination (0 
to 10 W/cm²) until no further blinking events were observed. 
 
SMLM analysis 
Super-resolved images of TLR4_mEos2, CD86_mEos2, and CTLA-4_mEos2 were reconstructed 
with rapidSTORM software and custom-written software (Localization microscopy analyzer 
(LAMA) (68, 69). In rapidSTORM, images were reconstructed and a localization list was 
generated; localizations that appeared with a brightness of less than 63 photons were not taken into 
account. Signals from mEos2, which appeared in consecutive camera frames within a radius of 90 
nm were grouped together as a single localization by a Kalman filtering routine. The localization 
precision was determined with a nearest neighbor analysis (NeNa) (48). To exclude mEos2 
particles that may not have photobleached until the end of the experiment, we excluded all clusters 
from the analysis that showed blinking events in the last 1000 frames of the image stack. This 
ensured that the blinking statistics were not distorted by clusters with incomplete blinking cycles. 
For oligomerization analysis, the number of blinking events was extracted from individual mEos2 
clusters; clusters with a low brightness, a diameter greater than 120 nm, or low circularity, as well 
as clusters with any localization nearby (distance at least 60 nm) were discarded (Fig. 1). At least 
500 clusters per condition were analyzed. For each condition, at least 9 different cells were taken 
into account from at least four independent experiments per condition. Frequency distributions of 
the number of blinking events were approximated by fitting functions, which describe the blinking 
statistics of simple fluorophores (39). For example, the blinking statistics of a monomer (one 
fluorophore) is given by: 
𝑝0(𝑛) =  𝑝(1 − 𝑝)
𝑛 (Eq. 1) 
 
The blinking statistics of a dimer is given by: 
𝑝1 (𝑛) = 𝑝(1 − 𝑝)
𝑛−1𝑝(1 − 𝑞)𝑛 + (1 − 𝑝)𝑞 (Eq. 2) 
 
Whereas the blinking statistics of a mixed population of monomers and dimers is given by: 
𝑝0/1 = 𝑝 (1 − 𝑝)
𝑛 𝑓 + (1 − 𝑓)𝑝 ((1 − 𝑝)(𝑛−1))(𝑝(1 − 𝑞)𝑛 + (1 − 𝑝)𝑞) (Eq. 
3) 
 
We used the parameters p and q, where p describes the fraction of fluorophores that did not undergo 
blinking after initial photoactivation and q describes the fraction of damaged, undetected 
fluorophores; 𝑓 describes the fraction of monomeric protein within a mixed population (39). To 
analyze a mixed population of monomers and dimers, we used a weighted average. Only cells with 
low quantities of exogenous protein were used for analysis to avoid artifacts due to overexpression 
and to minimize the chance of overlapping blinking fluorophores. 
 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism software (GraphPad). Data are shown as 
means ± SEM of at least three independent measurements and were compared by one-way analysis 
of variance (ANOVA) with Bonferroni correction (with a confidence interval of 95%). P < 0.05 
was considered to be statistically significant. 
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Fig. 1. Single-molecule, super-resolution imaging of membrane protein clusters and 
determination of protein stoichiometry in protein clusters. (A) A super-resolved SMLM image 
is generated from a stack of images by determining the position of each molecule with nanometer 
precision. From the super-resolved image, single clusters are selected, and the number of 
fluorescence bursts within each cluster is determined. The number of blinking events, which is the 
number of fluorescence bursts minus one, is plotted as a histogram and provides information on 
the average molecule count within the protein clusters. The selection of clusters for quantitative 
analysis is based on the super-resolved image and removes overlapping clusters, clusters with 
irregular shape or size, or clusters that are composed of only very few points (red boxes). Selected 
clusters (green boxes) were further analyzed. Illustration of these selection criteria is demonstrated 
for dimeric CTLA-4_mEos2. (B and C) PALM image (B) of HEK 293 cells expressing the 
monomeric protein CD86_mEos2 (inset: PDB 1NCN) in the plasma membrane and (C) the 
blinking distribution with fit function. (D and E) PALM image (D) of HEK 293 cells expressing 
the dimeric protein CTLA-4_mEos2 (inset: PDB 3OSK) in the plasma membrane and (E) the 
blinking distribution with fit function. Scale bars: 200 nm. Data are from at least 500 clusters from 
at least 9 cells recorded in at least three independent experiments. 
 
Fig. 2. Stoichiometry analysis of TLR4_mEos2 in HEK 293 cells in situ. (A) Model-derived fit 
functions describing the blinking histogram for a protein monomer (purple), dimer (blue), and a 
weighted average of monomer and dimer in equal parts (green). See Materials and Methods for 
further details. (B) Analysis of the distribution of blinking events in HEK 293 cells transiently 
transfected with plasmid encoding TLR4_mEos2, but lacking the coreceptors CD14 and MD2. We 
calculated the parameter p, which reports on the fraction of molecules that did not blink, as p = 
0.31. (C) Analysis of blinking events in HEK293_CD14MD2 cells that were transfected with 
plasmid encoding TLR4_mEos2, but were not treated with LPS. TLR4 was found in a mixed 
population of monomers (52%) and dimers (48%). p = 0.32; q = 0.29. (D to F) 
HEK293_CD14MD2 cells transfected with plasmid encoding TLR4_mEos2 were treated with 
LPSEC (D), LPSSM (E), or LPSRS (F) and then the distribution of blinking events was determined. 
Treatment with (D) LPSEC induced a weighted average of monomeric (26%) and dimeric (74%) 
TLR4 (used values: p = 0.32; q = 0.29). (E) For treatment with LPSSM, 27% monomers and 73% 
dimers were detected (used values: p = 0.32; q = 0.29). (F) Treatment with LPSRS led to monomeric 
TLR4 only, p=0.33. Data are from at least 500 clusters from at least 9 cells recorded in at least 
three independent experiments. 
 
Fig. 3. Measurement of NF-κB– and IRF3-dependent luciferase activities to determine the 
potencies of different LPS chemotypes and the functionality of TLR4_mEos2. (A to C) 
HEK293_CD14MD2 cells were transiently transfected with (A) plasmids encoding EGFP, 
TLR4_GFP, or TLR4_mEos2 and an NF-κB–dependent luciferase reporter plasmid, (B) plasmid 
encoding TLR4_mEos2 together with the NF-κB–dependent luciferase reporter plasmid, or (C) 
plasmid encoding TLR4_mEos2 together with the IRF3-dependent luciferase reporter plasmid. 
Luciferase activity was detected in (A) unstimulated cells and LPSEC-stimulated cells; (B) 
untreated cells (control) and in cells stimulated with LPSEC or LPSSM in the absence or presence 
of LPSRS, as indicated; or (C) treated with LPSEC or LPSSM or left untreated (control). Intensity 
values were normalized to untreated EGFP-expressing cells (A) or to control cells (B and C). Data 
are means ± SEM of at least three experiments. *P < 0.05, **P < 0.01, ***P < 0.001 by one-way 
ANOVA followed by Bonferroni correction. 
  
Table 1. Values for the calibration proteins used for quantitative SMLM. Determination of the 
parameters p and q derived from the quantitative analysis of the blinking number distributions for the 
calibration proteins CD86_mEos2 and CTLA-4_mEos2. The average localization precision calculated with 
a nearest neighbor analysis is shown. Data are means ± SEM. N, number. 
 
 p  q  Ncells Nanalyzed clusters Average localization precision (nm) 
CD86_mEos2 0.32 - 9 504 15.1 ± 0.4  
CTLA-4_mEos2 - 0.29 10 844 16.1 ± 1.0  
 
  
   
   
 
